Zfyve16 Regulates the Proliferation of B-lymphoid Cells

Xuemei Zhao,Donghe Li,Qingsong Qiu,Bo Jiao,Ruihong Zhang,Ping Liu,Ruibao Ren
DOI: https://doi.org/10.1007/s11684-017-0562-3
2017-01-01
Frontiers of Medicine
Abstract:Zfyve16 (a.k.a. endofin or endo some-associated F YVE-domain prote in ), a member of the FYVE-domain protein family, is involved in endosomal trafficking and in TGF-β, BMP, and EGFR signaling. The FYVE protein SARA regulates the TGF-β signaling pathway by recruiting Smad2/3 and accelerating their phosphorylation, thereby altering their susceptibility to TGF-β-mediated T cell suppression. Zfyve16 binds to Smad4 and their binding affects the formation of Smad2/3-Smad4 complex in TGF-β signaling. However, the in vivo function of Zfyve16 remains unknown. In this study, we generated a Zfyve16 knockout mouse strain ( Zfyve16 KO ) and examined its hematopoietic phenotypes and hematopoietic reconstruction ability. The proportion of Tcells in the peripheral blood of Zfyve16 KO mice increases compared with that in wild-type mice. This finding is consistent with the role of Zfyve16 in facilitating TGF-β signaling. Unpredictably, B cell proliferation is inhibited in Zfyve16 KO mice. The proliferation potential of Zfyve16 KO B-lymphoid cells also significantly decreases in vitro . These results suggest that Zfyve16 inhibits the proliferation of T cells, possibly through the TGF-β signaling, but upregulates the proliferation of B-lymphoid cells.
What problem does this paper attempt to address?